A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma

Although various platelet-rich plasma (PRP) kits are commercially available, the efficacy of these kits for knee osteoarthritis (KOA) has not been fully investigated. This study aimed to investigate the short-term results of leukocyte-poor PRP (LP-PRP) and the factors that contribute to its efficacy...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Naoya Kikuchi, Tomokazu Yoshioka, Norihito Arai, Hisashi Sugaya, Kojiro Hyodo, Yu Taniguchi, Kosuke Okuno, Akihiro Kanamori, Masashi Yamazaki
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
R
Acceso en línea:https://doaj.org/article/f2f502971cf84134a9d1cbfba74ad638
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f2f502971cf84134a9d1cbfba74ad638
record_format dspace
spelling oai:doaj.org-article:f2f502971cf84134a9d1cbfba74ad6382021-11-11T17:44:31ZA Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma10.3390/jcm102151212077-0383https://doaj.org/article/f2f502971cf84134a9d1cbfba74ad6382021-10-01T00:00:00Zhttps://www.mdpi.com/2077-0383/10/21/5121https://doaj.org/toc/2077-0383Although various platelet-rich plasma (PRP) kits are commercially available, the efficacy of these kits for knee osteoarthritis (KOA) has not been fully investigated. This study aimed to investigate the short-term results of leukocyte-poor PRP (LP-PRP) and the factors that contribute to its efficacy. We retrospectively reviewed 124 patients with KOA who were treated with LP-PRP. White blood cell (WBC) and platelet counts in the whole blood and the LP-PRP were measured. KOA severity was assessed using radiography. Clinical evaluation was performed both prior to injection and after an average of 3.3 weeks after the injection using the Japanese Knee Osteoarthritis Measure (JKOM). Responders were defined based on the JKOM. The contributing factors for responders were examined using a multivariate logistic analysis. The responder rate was 58.1% and the contributing factors for responders were a higher visual analog scale score before injection, WBC count in whole blood, and platelet concentration ratio of LP-PRP. The LP-PRP improved the clinical scores in the short term. Certain patient characteristics before injection and the concentration ratio of LP-PRP may be predictors of its efficacy; these may provide clues for elucidating which components of LP-PRP act on KOA pathologies.Naoya KikuchiTomokazu YoshiokaNorihito AraiHisashi SugayaKojiro HyodoYu TaniguchiKosuke OkunoAkihiro KanamoriMasashi YamazakiMDPI AGarticleplasma rich in growth factorplatelet-rich plasmaknee osteoarthritisMedicineRENJournal of Clinical Medicine, Vol 10, Iss 5121, p 5121 (2021)
institution DOAJ
collection DOAJ
language EN
topic plasma rich in growth factor
platelet-rich plasma
knee osteoarthritis
Medicine
R
spellingShingle plasma rich in growth factor
platelet-rich plasma
knee osteoarthritis
Medicine
R
Naoya Kikuchi
Tomokazu Yoshioka
Norihito Arai
Hisashi Sugaya
Kojiro Hyodo
Yu Taniguchi
Kosuke Okuno
Akihiro Kanamori
Masashi Yamazaki
A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma
description Although various platelet-rich plasma (PRP) kits are commercially available, the efficacy of these kits for knee osteoarthritis (KOA) has not been fully investigated. This study aimed to investigate the short-term results of leukocyte-poor PRP (LP-PRP) and the factors that contribute to its efficacy. We retrospectively reviewed 124 patients with KOA who were treated with LP-PRP. White blood cell (WBC) and platelet counts in the whole blood and the LP-PRP were measured. KOA severity was assessed using radiography. Clinical evaluation was performed both prior to injection and after an average of 3.3 weeks after the injection using the Japanese Knee Osteoarthritis Measure (JKOM). Responders were defined based on the JKOM. The contributing factors for responders were examined using a multivariate logistic analysis. The responder rate was 58.1% and the contributing factors for responders were a higher visual analog scale score before injection, WBC count in whole blood, and platelet concentration ratio of LP-PRP. The LP-PRP improved the clinical scores in the short term. Certain patient characteristics before injection and the concentration ratio of LP-PRP may be predictors of its efficacy; these may provide clues for elucidating which components of LP-PRP act on KOA pathologies.
format article
author Naoya Kikuchi
Tomokazu Yoshioka
Norihito Arai
Hisashi Sugaya
Kojiro Hyodo
Yu Taniguchi
Kosuke Okuno
Akihiro Kanamori
Masashi Yamazaki
author_facet Naoya Kikuchi
Tomokazu Yoshioka
Norihito Arai
Hisashi Sugaya
Kojiro Hyodo
Yu Taniguchi
Kosuke Okuno
Akihiro Kanamori
Masashi Yamazaki
author_sort Naoya Kikuchi
title A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma
title_short A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma
title_full A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma
title_fullStr A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma
title_full_unstemmed A Retrospective Analysis of Clinical Outcome and Predictive Factors for Responders with Knee Osteoarthritis to a Single Injection of Leukocyte-Poor Platelet-Rich Plasma
title_sort retrospective analysis of clinical outcome and predictive factors for responders with knee osteoarthritis to a single injection of leukocyte-poor platelet-rich plasma
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/f2f502971cf84134a9d1cbfba74ad638
work_keys_str_mv AT naoyakikuchi aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT tomokazuyoshioka aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT norihitoarai aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT hisashisugaya aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT kojirohyodo aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT yutaniguchi aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT kosukeokuno aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT akihirokanamori aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT masashiyamazaki aretrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT naoyakikuchi retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT tomokazuyoshioka retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT norihitoarai retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT hisashisugaya retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT kojirohyodo retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT yutaniguchi retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT kosukeokuno retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT akihirokanamori retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
AT masashiyamazaki retrospectiveanalysisofclinicaloutcomeandpredictivefactorsforresponderswithkneeosteoarthritistoasingleinjectionofleukocytepoorplateletrichplasma
_version_ 1718432036372348928